Gate News message, April 21 — Wantai Biotech (603392) reported its first annual loss since listing in 2020, with 2025 net loss attributable to parent company reaching 398 million yuan (approximately $55 million), while revenue declined 18.99% year-over-year to 1.819 billion yuan. The company attributed the decline to domestic vaccine procurement policies, intensified industry competition, and consumer vaccine hesitancy.
The nine-valent HPV vaccine, which launched in 2025 as China’s first domestically developed nine-valent HPV vaccine and the world’s second, completed its first inoculation on September 9, 2025. However, the company stated in its financial report that the vaccine “remains in the market entry phase and has not yet generated scaled profit contributions,” failing to offset losses from inventory disposal of bivalent HPV vaccine and government procurement price reductions. The vaccine segment revenue fell 24.63% year-over-year to 457 million yuan, with gross margin declining 43.18 percentage points.
The diagnostic segment generated 1.309 billion yuan in revenue, down 18.65% year-over-year, impacted by procurement price cuts and medical insurance policy adjustments. International revenue, however, surged 90.85% to 412 million yuan, driven by substantial growth in bivalent HPV vaccine exports. Wantai Biotech is advancing nine-valent HPV vaccine WHO prequalification preparations and has initiated Phase 3 clinical trials for male populations, with the first participant enrolled.
Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to
Disclaimer.
Related Articles
U.S. Stock Indices Rise at Open: Dow Jones Up 256 Points, S&P 500 and Nasdaq Also Gain
Gate News message, April 21 — The Dow Jones Industrial Average (U.S. benchmark equity index) opened Tuesday up 256.28 points, or 0.52%, reaching 49,698.84. The S&P 500 (U.S. broad market equity index) gained 9.89 points, up 0.14%, at 7,119.03, while the Nasdaq Composite (U.S. technology-heavy index)
GateNews7m ago
Trump Says Stock Market Rally During Iran War Surprised Him; Expected Dow Jones to Fall 20%
Gate News message, April 21 — U.S. President Donald Trump said in an interview that the stock market's rebound during the Iran war surprised him, as he had anticipated the Dow Jones index would decline 20%.
GateNews18m ago
TradFi Rise Alert: UNH (UnitedHealth) Rises Over 8%
Gate News: According to the latest Gate TradFi data, UNH (UnitedHealth) has surged by 8% in a short period. Current volatility is significantly higher than recent averages, indicating increased market activity.
GateNews19m ago
SpaceX Kicks Off IPO Roadshow with Analyst Meetings at Starbase and Memphis
Gate News message, April 21 — SpaceX has begun its pre-IPO roadshow this week, hosting private meetings for top Wall Street analysts from the aerospace and tech sectors in Texas and Tennessee as it works toward a late-June stock market debut. The company is targeting a $75 billion raise, with
GateNews20m ago
Deutsche Bank Survey Shows US Bitcoin Adoption Rose to 12% in March, Up from 7% in February
Gate News message, April 21 — An investor survey by German banking giant Deutsche Bank revealed that cryptocurrency adoption in the US rose to 12% in March, up from a low of 7% in February, returning to levels projected for July 2025.
The report highlighted recovery in institutional demand as a
GateNews30m ago
Vanke A to Distribute 864.54 Million Yuan in Principal and Interest on April 23
Gate News message, April 21 — Vanke A announced that its 2023 first-period medium-term note (MTN), ticker "23万科MTN001" (code 102381014), will mature on April 23, 2026. The bond, with an issuance size
GateNews31m ago
